Back

Dose-response and efficacy ceiling of zilebesiran: a bayesian non-linear spline meta-analysis of phase 1 and KARDIA phase 2 trials

29 August 2026 (14:15 - 15:00)
Organised by: Logo
Congress Presentation Part of: Therapeutic aspects for hypertension Pharmacotherapy ESC2026 Premium Access ESC Congress 2026 European Society of Cardiology

About the speaker

Photo
Mr Krish Sumir Keswani

Vadodara (India)

6 More presentations in this session

Presentation thumbnail
Nationwide use of antihypertensive combination therapy in the Czech Republic
Professor J. Vaclavik (Ostrava, CZ)
Abstract Slides Video
Presentation thumbnail
Beta-blockers in patients with uncomplicated arterial hypertension: data from the Campania Salute Network Registry
Doctor C. Basile (Stockholm, SE)
Abstract Slides Video
Presentation thumbnail
Autonomous closed-loop intravenous esmolol for systolic blood pressure regulation and beat-to-beat variability suppression with safety supervision: a large-animal validation study
Doctor J. Curneen (Galway, IE)
Abstract Slides Video
Presentation thumbnail
A multidimensional primary care intervention reduces sedentary behaviour and promotes behavioural readiness for physical activity in hypertension and diabetes patients
Doctor M. Marcolino (Belo Horizonte, BR)
Abstract Slides Video
Presentation thumbnail
The results of a standardized diagnostic care pathway in patients referred for difficult-to-treat hypertension: the IDENTIFY study
Miss K. Saville (Rotterdam, NL)
Abstract Slides Video

Access the full session

Session thumbnail
Therapeutic aspects for hypertension

The Event

Event poster

ESC Congress 2026

29 August 2026 14:15 CET
You may be interested in
thumbnail
Congress Presentation
siRNAs to lower blood pressure
28 August 2026
thumbnail
Congress Presentation
Pleiotropic effects of inclisiran on arterial structural and functional parameters
29 August 2025
thumbnail
Congress Presentation
Safety of potassium-binding agents in HFrEF: a meta-analysis of randomized trials
28 August 2026
thumbnail
Congress Presentation
Peri-ablation semaglutide exposure and atrial fibrillation recurrence: a meta-analysis of time-to-event outcomes
28 August 2026

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources